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Nowadays the use of magnetic nanoparticles (MNP) in medical applications has exceeded 
expectations. In molecular imaging, MNP based on iron oxide coated with appropriated materials 
have several applications in vitro and in vivo studies. For applications in nanobiotechnology these 
MNP must present some characteristics such as size smaller than 100 nanometers, high magnetization 
values, among others. Therefore the MNP have physical and chemical properties that are specific to 
certain studies which must be characterized for quality control of the nanostructured material. This 
study presents the synthesis and characterization of MNP of magnetite (Fe3O4) dispersible in water with 
perspectives in a wide range of biomedical applications. The characterization of the colloidal suspension 
based on MNP stated that the average diameter is (12.6±0.2) nm determined by Transmission Electron 
Microscopy where the MNP have the crystalline phase of magnetite (Fe3O4) that was identified by 
Diffraction X-ray and confirmed by Mössbauer Spectroscopy. The blocking temperature of (89±1) K, 
Fe3O4 MNP property, was determined from magnetic measurements based on the Zero Field Cooled 
and Field Cooled methods. The hysteresis loops were measured at different temperatures below and 
above blocking temperature. The magnetometry determined that the MNP showed superparamagnetic 
behavior confirmed by ferromagnetic resonance.
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1. Introduction
The synthesis of magnetic nanoparticles (MNP) has 
received great interest in recent years because of new 
physical and chemical properties of materials at nanoscale. 
Based on their mesoscopic physical, chemical, thermal and 
mechanical properties, and in conjunction with control of 
size, composition and morphology of growth, the synthesis 
of MNP lead to a wide range of specific technological 
applications1-4.
Among crystal polymorphs of iron (III) known, 
magnetite (Fe3O4) is a promising candidate for its 
biocompatibility and biodegradable activity5,6. Thus, 
iron oxide MNP with crystalline phase corresponding to 
magnetite appears as an important nanomaterial for various 
biomedical applications such as: (i) cellular therapy as cell 
labeling, targeting, and as a tool for cell-biology research 
to separate and purify cell populations, (ii) tissue repair; 
(iii) drug delivery, (iv) magnetic resonance imaging (MRI), 
(v) hyperthermia, (vi) magnetofection, among other7-9. 
In clinical applications, it is desirable MNP with sizes 
between 10 and 200 nm, because MNP larger than 200 nm 
can be filtered by the human spleen, and MNP smaller than 
10 nm can be removed by renal clearance10. The usefulness 
of MNP in medical applications is mainly related to the 
coating material, which are biocompatible, nontoxic and 
biodegradable. Among the commercial products based on 
MNP, Endorem® and Lumirem® are used as contrast agents 
in MRI to the liver and intestine, respectively.
Several synthesis processes are used in the development 
of MNP. For this reason, the conditions of synthesis are 
crucial to determine the physicochemical properties of 
MNP such as concentration and pH of the solution as 
well as the mode of heat treatment used11,12. The most 
important methods described in the literature to prepare 
MNP, which are suitable for biomedical applications13-16, 
are: co-precipitation, microemulsions polyol process, high 
temperature decomposition of organic precursors, assisted 
sonochemical, electrochemical methods and sol-gel process. 
It is important for biomedical applications, to know the 
synthesis process of the nanomaterial – which needs to be 
dispersed in water – and also, the study of biocompatibility 
and toxicity that must possess adequate characteristics for 
such applications. In the case of iron oxide MNP coated with 
biocompatible material determining the crystal phase, the 
average diameter and the magnetic property are important, 
which can be measured using several techniques.*e-mail: javierbm@einstein.br
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This paper presents a synthesis route to prepar MNP 
as well as the morphological, structural and magnetic 
characterization of the material synthesized to control quality 
of these MNP that are presented as promising particles in 
biomedical applications. Morphological characterization 
was performed using the technique of transmission electron 
microscopy (TEM). The structural characterization was 
conducted using the technique of X-ray diffraction (XRD) 
and Mössbauer spectroscopy. The magnetic characterization 
was done using magnetometry (SQUID) and ferromagnetic 
resonance (FMR).
2. Experimental
2.1. Magnetic fluid preparation
An alcoholic solution 200 ml of FeCl23.6H2O (Aldrich) 
0.25M, in butanol, was prepared and heated under 
stirring to 90 °C. So, 8 mL of concentrated surfactant 
nonilpheniletoxilated (Renex 95®), another solution of 
concentrated ammonia was prepared containing 4% (in 
volume) of surfactant (Renex 95®).
The ammonia solution was added drop by drop to 
the iron III solution to promote precipitation of iron oxi-
hydroxide. The precipitate was centrifuged and washed with 
butanol containing 4% (in volume) of surfactant at 90 °C 
in order to eliminate as possible the ammonium chloride. 
After five washing cycles, we observed the peptization 
of the precipitate and formation of 100 mL of true sol. 
Subsequently, 8 mL of surfactant (Renex 95®) and 10 mL 
of liquid paraffin (Nujol®) were added to the sol.
The sol was dried at 70 °C under stirring to aid butanol 
evaporation. After that, a viscous dark liquid was obtained. 
The viscous dark liquid was dried in a hermetically closed 
sintering chamber at 250 °C under N2 pressure (2 atm) for 
half-hour.
After complete the procedure described above, we 
obtained a black paste. This paste was dispersed in water 
containing 4% of surfactant (Renex 95®) that formed a 
magnetic fluid.
2.2. Characterization methods
The crystalline phase of the redispersible black paste 
was determined by X-ray diffraction (XRD). The XRD 
data were collected between 10° < 2θ < 60° using the Cu-
Kα radiation filtered by Ni in step scanning mode (0.05° 
for 10 s).
Mössbauer spectroscopy (MS) measurements were 
performed at 78 K and 294 K using a constant-acceleration 
spectrometer in transmission geometry with a 57Co/Rh 
source. To calibrate isomer shifts and velocity scale, we 
used a foil of α-Fe at 294 K. For magnetic measurements, 
as-prepared samples were stored in closed containers before 
quenching the magnetite/carrier mixture below its freezing 
point (~268 K) at room temperature.
Transmission electronic microscopy (TEM) was 
employed to check the size distribution of nanoparticles in 
the magnetic fluid. The magnetic fluid was dried at 70 °C by 
water evaporation. Fine powders were aspersed on a cooper 
grille containing parlodion and charcoal, and examined 
using a LEO 906E equipment operating at 80 KV.
The nanoparticles size poly-dispersity was analyzed 
from the TEM micrographies using the image analysis 
program java ImageJ v 1.33u[17]. Mean diameters were 
thus obtained by fitting the experimental data with a 
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A commercial SQUID magnetometer was employed 
to perform static and dynamic measurements as a function 
field, temperature and driving frequency. Zero-field-cooled 
(ZFC) and field-cooled (FC) curves were taken in applied 
magnetic fields up to 7 T, between 5K and 250 K to avoid 
melting of the solid matrix (solvent).
We used a ferromagnetic resonance (FMR) to verify 
the superparamagnetic behavior and to evaluate the 
nanoparticles geometry. The derivative of the FMR 
absorption spectrum was obtained using a Brucker X band 
homodyne spectrometer, model EMX-12 operating at 
frequency of 9.2GHz and modulated at 100 KHz with a TE102 
dominant mode cavity. The measurements were carried out 
at room temperature.
3. Results and Discussion
Figure 1 shows the XRD profile of the redispersible 
powder sample. We could observe a large low crystallinity 
zone with 2θ = 30.19°. Typical diffuse profiles of iron 
oxide phases are added to the background and can be 
attributed to maghemite (γ-Fe2O3, ICSD Collection Code 
79196), magnetite (Fe3O4, ICSD Collection Code 15840) 
Figure 1. Diffractogram of the synthesized sample, the inset shows 
the possible existence of iron oxides magnetite (M), maghemite (m) 
and / or hematite (H).
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or hematite (α-Fe2O3, ICSD Collection Code 66756) 
corresponding to small crystalline domains. Following the 
profile analyses, the background was subtracted and the 
presence of two intense peaks between 25 and 40 (2θ°) can 
be noted. In order to access the structural parameters, the 
Κα1-Κα2 doublet separation (Rachinger correction) and 
background corrections were performed by using a pseudo-
Voigt function (PVF), in a interactive method of profile 
fitting by least squares method19,20. The peak position and 
correspondent phase were chosen as initial parameters. The 
inset of the Figure 1 shows the results of the fit procedure 
and the result exhibits basically peaks due maghemite phase. 
On other hand, the XRD results point out to a mixed phase 
of iron oxide constituted by Fe2+ and Fe3+ ions.
The structural characterization by XRD of MNP 
is complex, because the diffractogram shows broad 
and overlapping diffraction peaks due to finite number 
of scattering crystalline planes that are causing the 
positions and shapes of the peaks to vary according to 
the nanoparticles size, making difficult to interpret the 
diffractograms. It is important to mention that in the case 
of existence or coexistence of magnetite, maghemite and 
/ or hematite it is difficult to identify the crystalline phase 
formed from the techniques of X-ray diffraction, because 
they do not have obvious structural differences shown in the 
inset Figure 1, for example, peak M(220) and m(206), and 
peak M(311) and m(311). Therefore, alternative methods 
are needed that allow to individualize these oxides, such as 
Mössbauer spectroscopy technique that allows to perform 
local measures and sensitive to the vicinity of the chemical 
elements, thereby allowing a better identification of the 
phases formed.
For better identification of magnetic phases presented in 
the synthesized sample we used a Mossbauer spectroscopy, 
which showed a structure constituted with two different 
magnetic ions occupying two classes of binding sites in the 
crystal lattice, tetrahedral (A) and octahedral (B). The room 
temperature Mossbauer spectra in Figure 2a corresponds 
to magnetite (Fe3O4), where all changes in the interactions 
(AA, AB and BB) are aligned anti-parallel. The behavior 
ferrimagnetism is because of strong interaction of AB. The 
favorable antiparallel interaction of A with B induces the 
parallel ordering of all the spins of A and B and the system 
is ordered ferrimagnetism.
The room temperature Mossbauer spectra is presented in 
Figure 2a. The hyperfine parameters for this latter presented 
in Table 1 agree with those for A and B sites of magnetite. 
In agreement with the expected superparamagnetic in our 
sample at T = 78 K, described in Figure 2b, the spectrum 
showed nearly total magnetic order, although relaxing 
particles could still be inferred from the curved background. 
T=4.2 K in Figure 2c the spectra could be fitted with only 
two magnetically ordered components of hyperfine fields 
B1 = 50.7(4) T and B2 = 52.9(4) T, which correspond to sites 
A (Fe3+ ions) and B (Fe2+ Fe3+ ions) respectively. Both sites 
showed nearly null quadrupole splitting QS and intensity 
ratio B:A ~ 2:1. All these hyperfine parameters are very close 
to those of bulk magnetite at this temperature, without any 
indication of finite-size effects. These bulk-like properties 
are seemingly originated in a well-ordered local structure 
within the particles. However, the large spectral linewidth 
(Γ=0.7 mm/s) observed in the sample suggests the presence 
of a second phase.
The literature describes the average diameter calculation 
of the nanoparticles core by the XRD technique. This type 
of analysis is based on the diffraction line profile, where the 
Scherrer21 method is the most used for its simplicity, which 
may lead to results with little accuracy associated with the 
complexity of the diffraction pattern. However, exist more 
efficient methodologies for this calculation such as the 
Warren-Averbach modified method21. Given the complexity 
of determining the sample crystal phase of XRD spectrum, 
this calculation was not performed in our study. Therefore, 
the TEM technique was chosen to analyze the measurement 
of average diameter for the synthesized nanoparticles..
Table 1. Hyperfine parameters.
T (K) Bhyp (T) QS (mm/s) IS (mm/s) I (%)
294 A 49.8(2) 0.0(1) 0.32(8) 53(8)
B 44.0(2) 0.0(1) 0.50(8) 47(8)
78 A 52.3(2) 0.1(1) 0.50(8) 57(11)
B 48.0(3) 0.0(1) 0.52(8) 43(11)
4.2 A 52.9(1) 0.0(1) 0.50(8) 67(3)
B 50.7(1) 0.0(1) 0.52(8) 36(3)
Figure 2. Mössbauer spectrum: (a) room temperature, (b) 78 K 
e (c) 4.2 K.
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As regards the morphological characterization, 
TEM technique allowed to observe the morphology and 
distribution of MNP in colloidal suspension after drying by 
lyophilization of the sample (Figure 3). The size distribution 
was fitted to a log-normal function from the histogram (see 
inset of Figure 3) obtained from the micrograph. In setting 
the average diameter was found <DP> = 12.6 nm with a 
typical width sP = 0.2. The histogram was obtained by the 
analysis of micrograph (Figure 3) considering more than 
700 particles.
The Figure 4 shows magnetization curves taken in 
zero-field-cooling (ZFC) and field-cooling (FC) modes 
with H
app=100 Oe. The sample showed superparamagnetic 
behavior at room temperature, with blocking transition at 
TB = 89(1) K (H=100 Oe). The lack of overlapping Zero-
field- cooled (ZFC) and field-cooled (FC) curves indicated 
that the largest particles were blocked at 300 K, the highest 
temperature obtained in our study. The great value of TB and 
broader peak of ZFC data were consistent with the average 
size of MNP and the size distribution.
Figure 5 shows the magnetization versus field plot at 
temperatures of 150 K (a) and 10 K (b). Figure 5a shows 
that hysteresis disappeared with a little remanence and 
coercirvity (H
c
), indicating the absence as a long range 
magnetic dipole-dipole interaction among the assemblies 
of superparamagnetic nanoparticles. When the temperature 
was  decreased to 10 K, the magnetization of the sample 
increased with a symmetric hysteresis loop, and showed 
a transition from superparamagnetic to ferromagnetic 
behavior (Figure 5b).
For T > TB the coercitivity HC of the particles is zero 
within experimental error, whereas below TB the coercive 
field increases up to a value HC = 330(5) Oe at 2 K. 
This value of HC is within the (broad) range reported for 
nanostructured iron oxide nanoparticles. The remanence 
to saturation ratio R = MR/MS measured at 5 K is 0.27, 
smaller than the theoretically expected 0.5 for randomly 
oriented grains22, some studies had proposed that R > 0.5 
and R < 0.5 values should be expected for systems with 
ferro- and antiferromagnetic interactions, respectively. Thus, 
the presented R = 0.27 value suggests that the interparticle 
interactions are of antiferromagnetic nature.
Findings of this study shows that Ms of synthesized 
MNP was lower than the corresponding bulk phase. 
Studies on the reduction in magnetization in iron oxide 
nanoparticles (γ-Fe2O3, Fe3O4) had reported that reduction 
is because of the existence of noncollinear spins at the 
surface of the nanoparticles5,23. Varanda et al.24 described 
Figure 3. Transmission electron micrograph of the synthesized 
ferrofluid (77500X). The inset shows the histogram of size 
distribution of MNP which was obtained from TEM data to 
approximate a log-normal distribution with mean diameter 
<DP> = 12.6 nm with typical width sP = 0.2.
Figure 4. Curve fitting ZFC and FC measurements at 100 Oe.
Figure 5. Magnetization as a function of magnetic field at 
temperatures of 150 K (a) and 10 K (b).
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a linear correlation between Ms and nanoparticles size 
suggesting that defects at the nanoparticle surface can 
influence the magnetic properties5,24. The surface curvature 
of particles was higher for nanoparticles which stimulated 
disordered crystal orientation on the surface resulting in 
significantly decreased Ms5. The identification of the hard 
crystalline phase by X-ray diffraction, Figure 1, suggests 
reduction in the magnetization which is associated with 
the surface feature of the MNP. This loss of magnetisation 
depends primarily on the crystalline magnetic anisotropy 
energy constant, K indicating that magnetization losses 
are associated with the existence of a magnetically dead 
layer, ~ 1 nm thick, caused by an asymmetric environment 
effect on surface atoms5,25. The magnetic behavior depends 
on MNP TB, TB being dependent on the size of the MNP. 
MNP with low values of TB exhibit superparamagnetic 
properties. For high values of the TB MNP showed 
ferromagnetic behavior10. For MNP average diameter 
<30nm the remanence and coercivity are very small so that 
producing a superparamagnetic behavior of MNP26. The 
values of remanence and coercivity, almost zero, are shown 
in the hysteresis loops of the nanomaterial. The figure 5 
shows that the synthesized MNP has the superparamagnetic 
property which is a desirable characteristic of a nanomaterial 
in biomedical applications. Studies show that the MNP 
coating with non-magnetic materials decrease saturation 
magnetization values27,28. A magnetically ineffective layer 
on the MNP surface interferes in determining the particle 
sizes calculated using magnetization data smaller than values 
calculated from measurements performed by structural 
techniques such as XRD and TEM morphology29. This 
analysis enabled us to state that MNP with crystallization 
of the magnetite synthesized under different conditions 
differ from MNP’s magnetic properties that are attributed to 
changes in the structural disorder, the creation of antiphase 
boundaries or the existence of a magnetically dead layer in 
the surface of MNP5,30-32.
The magnetic properties of synthesized MNP in 
colloidal suspension were also studied by FMR. The FMR 
spectrum obtained at room temperature of the ferrofluid 
synthesized (Figure 6) showed two resonance lines whose 
parameters are shown in Table 2. The main resonance 
(g=2.0) came from the Fe3+ spins interactions, however, 
such interactions showed a superparamagnetic behavior33-39 
characterized by the presence of clusters. This signal consists 
of a strong absorption slightly asymmetric, whose large 
width is attributed to the strong interaction between Fe 
ions (cluster of clusters of Fe3+ ions by a strong exchange 
interaction). The exchange interaction between spins aligned 
antiparallel means that a broadening of resonance lines exist 
and this extension depends on the concentration of iron ions.
A second additional line was observed, but with low 
intensity, suggesting the presence of traces of Fe3+ (g=4.3) 
in the form of ions isolated trapped between oxygen atoms 
in sites that could provide local symmetry tetrahedral or 
octahedral, corresponding to iron paramagnetic. This line, 
presented by low intensity in the commercial ferrofluid is 
attributed to the existence of a paramagnetic complex of Fe3+ 
in the sample or the thermal fluctuations of the anisotropy 
axis of the magnetic particle33,34.
The analysis of the FMR spectrum obtained at room 
temperature allows to conclude that the synthesized sample 
has a superparamagnetic property40,41 which is required for 
several applications. We did not perform a detailed analysis 
of FMR spectrums in the studied sample. It could be made 
by obtaining spectrums achieved within the temperature 
range from 4K to room temperature, which allowed the 
analysis of various parameters typically originated from 
iron oxide nanoparticles40,41. In the FMR analysis as a 
function of temperature, we could observe that the peak to 
peak amplitude varied because randomly oriented dispersed 
ferromagnetic particles the width of absorption line is a 
monotonic function of temperature. At low temperature, 
the line width is larger due to the particles dispersion in the 
direction of the anisotropy field, because as temperature 
decreases, isotropic magnetic moments are formed and 
causes a decrease in the line width40,42.
To determine nanostructured material characteristics, 
without the need to make a detailed analysis along with 
the toxicity and biocompatibility tests at biological level, 
is enough to predict the potential  application in molecular 
imaging and nanomedicine43. The biological part was not 
the objective of this work: however, because of the MNP 
properties and the character of biocompatible coating, the 
Figure 6. FMR spectrum of the synthesized ferrofluid at room 
temperature. In the inset the resonance is enhanced in g=4.3.








Resonance 1 3362 ± 5 (6.0 ± 0.3)×102 2.0030 ± 0.0001
Resonance 2 1564.3 ± 0.5 47 ± 9 4.3044 ± 0.0001
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possible biomedical applications of the synthesized material 
are: (i) Because of superparamagnetic character, the sample 
can be used as a negative contrast agent for weighted images 
in the transverse relaxation time (T2) in magnetic resonance 
imaging44; (ii) the biocompatible coating and the property 
of being dispersed in an aqueous medium is essential for 
biological applications during the intracelular labeling of 
different cell lineages, for example, tumorigenic cells45; (iii) 
the superparamagnetic characteristic of the nanomaterial is 
a property that can facilitate the nanoparticles uptake by the 
cells through the use of an external static magnetic field46-48; 
(iv) in the magneto hyperthermia, where selective thermal 
ablation of tumor is made using MNP exposed to alternating 
magnetic field49,50; (v) MNP stability in the blood would 
allow the MNP to be guided or directed through a magnetic 
field gradient for targets such as tumor tissue, allowing the 
nanomaterial accumulation in the tumor tissue of interest47,51.
4. Conclusions
A chemical synthesis route was used to produce a 
ferrofluid-based MNP redispersible in water and different 
techniques were used to determine the characteristics of 
synthetized MNP.
This study reveals that MNP have an average diameter 
(12.6±0.2) nm as evidenced by the TEM technique. 
XRD showed the crystalline phase of iron oxide could 
correspond to magnetite, maghemite or hematite, but the 
characterization by Mössbauer determined the crystalline 
phase corresponds to magnetite (Fe3O4). The Mössbauer 
spectra at T = 294K showed that nanoparticles are in 
superparamagnetic state. The magnetization measurements 
showed ZFC and FC transition to the blocking state 
TB = (89 ± 1) K. Measure of magnetization as a function of 
the field showed a typical behavior of superparamagnetism 
in material because there were no coercitivity for T>TB the 
hysteresis cycles. However, when the temperature decreases 
below the blocking temperature, the magnetization of the 
sample increases with symmetrical hysteresis loop, showing 
a transition from superparamagnetic to ferromagnetic 
behavior. The study by FMR at room temperature showed 
that the ferrofluid reveals superparamagnetic behavior.
The average diameter of MNP characterized by TEM 
revealed to be ideal for in vitro studies. The crystalline 
phase of magnetite identified by Mössbauer is the most 
widely used in biological applications. The property of 
superparamagnetism determined by magnetometry and 
FMR allows MNP to be used in the monitoring and tracking 
of MNP by MRI technique, as well as in the Magneto 
Hyperthermia technique.
We believe synthetized nanomaterial has a potential for 
biomedical applications. Nonetheless, it is clear that both 
in vitro and in vivo studies are necessary to determine the 
applicability of this sample.
Acknowledgments
This work was supported by Instituto Israelita de Ensino 
e Pesquisa Albert Einstein - IIEPAE, FINEP, CAPES, CNPq 
and FAPESP.
References
1. Lin MM, Kim DK, El Haj AJ and Dobson J. Development 
of Superparamagnetic Iron Oxide Nanoparticles (SPIONS) 
for Translation to Clinical Applications. IEEE transactions 
on Nanobioscience. 2008; 7(4):298-305. http://dx.doi.
org/10.1109/TNB.2008.2011864
2. Teja AS and Koh PY. Synthesis, properties, and applications of 
magnetic iron oxide nanoparticles. Progress in Crystal Growth 
and Characterization of Materials. 2009; 55(1-2):22-45. http://
dx.doi.org/10.1016/j.pcrysgrow.2008.08.003
3. Kim J, Piao Y and Hyeon T. Multifunctional nanostructured 
materials for multimodal imaging, and simultaneous imaging 
and therapy. Chemical Society Reviews. 2009; 38(2):372-390. 
http://dx.doi.org/10.1039/b709883a
4. Shubayev VI, Pisanic Ii TR and Jin S. Magnetic nanoparticles for 
theragnostics. Article Advanced Drug Delivery Reviews. 2009; 
61(6):467-477. http://dx.doi.org/10.1016/j.addr.2009.03.007
5. Gupta AK and Gupta M. Synthesis and surface engineering 
of iron oxide nanoparticles for biomedical applications. 
Biomaterials. 2005; 26(18):3995-4021. http://dx.doi.
org/10.1016/j.biomaterials.2004.10.012
6. Xie J, Xu CJ, Xu ZC, Hou YL, Young KL, Wang SX et al. 
Linking Hydrophilic Macromolecules to Monodisperse 
Magnetite (Fe3O4) Nanoparticles via Trichloro-s-triazine. 
Chemistry of Materials. 2006; 18(23):5401-5403. http://dx.doi.
org/10.1021/cm061793c
7. Arbab AS, Bashaw LA, Miller BR, Jordan EK, Lewis BK, 
Kalish H et al. Characterization of Biophysical and Metabolic 
Properties of Cells Labeled with Superparamagnetic Iron 
Oxide Nanoparticles and Transfection Agent for Cellular MR 
Imaging. Radiology. 2003; 229(3):838-846. http://dx.doi.
org/10.1148/radiol.2293021215
8. Pankhurst QA, Connolly J, Jones SK and Dobson J. 
Applications of magnetic nanoparticles in biomedicine. Journal 
of Physics D: Applied Physics. 2003; 36:R167. http://dx.doi.
org/10.1088/0022-3727/36/13/201
9. Sensenig R, Sapir Y, MacDonald C, Cohen S and Polyak 
B. Magnetic nanoparticle-based approaches to locally target 
therapy and enhance tissue regeneration in vivo. Nanomedicine. 
2012; 7(9):1425-1442. http://dx.doi.org/10.2217/nnm.12.109
10. Chatterjee J, Haik Y and Chen Ch-J. Size dependent magnetic 
properties of iron oxide nanoparticles. Journal of Magnetism 
and Magnetic Materials. 2003; 257(1):113-118. http://dx.doi.
org/10.1016/S0304-8853(02)01066-1
11. Tang DP, Yuan R and Chai YQ. Direct Electrochemical 
Immunoassay Based on Immobilization of Protein-Magnetic 
Nanoparticle Composites on to Magnetic Electrode Surfaces 
by Sterically Enhanced Magnetic Field Force. Biotechnology 
Letters. 2006; 28(8):559-565. http://dx.doi.org/10.1007/
s10529-006-0017-4
12. Zboril R, Mashlan M and Petridis D. Iron(III) Oxides from 
Thermal ProcessesSynthesis, Structural and Magnetic 
Properties, Mössbauer Spectroscopy Characterization, and 
Applications. Chemistry of Material. 2002; 14(3):969-982. 
http://dx.doi.org/10.1021/cm0111074
13. Wu W, He Q and Jiang Ch. Magnetic Iron Oxide Nanoparticles: 
Synthesis and Surface Functionalization Strategies. Nanoscale 
Research Letters. 2008; 3:397-415. http://dx.doi.org/10.1007/
s11671-008-9174-9
14. Laurent S, Forge D, Port M, Roch A, Robic C, Elst LV et al. 
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, 
Vectorization, Physicochemical Characterizations, and 
2014; 17(3) 547
Mamani et al.
Biological Applications. Chemical Reviews. 2008; 108 
(6):2064-2110. http://dx.doi.org/10.1021/cr068445e
15. Mamani JB, Costa-Filho AJ, Cornejo DR, Vieira ED 
and Gamarra LF. Synthesis and characterization of 
magnetite nanoparticles coated with lauric acid. Materials 
Characterization. 2013; 81:28-36. http://dx.doi.org/10.1016/j.
matchar.2013.04.001
16. Brinker CJ and Scherrer GW. Sol-gel Science: The Physics 
of Chemistry of Sol-gel Processing. Academic Press, New 
York; 1990.
17. Rasvand W. Image Processing and Analysis in Java; 2004. 
Available from: <http://rsb.info.nih.gov/ij>. Acces in: 
18/12/2012.
18. O’Grady K and Bradbury A. Particle size analysis in ferrofluids. 
Journal of Magnetism and Magnetic Materials. 1983; 39(1-
2):91-94. http://dx.doi.org/10.1016/0304-8853(83)90407-9
19. Klug HP and Alexander L. X Ray Procedures for Polycrystalline 
and Amorfous Materials. 2nd ed. USA: John Wiley; 1974.
20. Brito GES. Evolução Estrutural e Microestrutural Durante a 
Secagem e Sinterização de Géis a Base de Óxido de Estanho. 
[Doctoral Thesis]. Brazil: Instituto de Química de Araraquara, 
Universidade Estadual Paulista Júlio de Mesquista Filho; 1997.
21. Dorofeev GA, Streletskii AN, Povstugar IV, Protasov AV and 
Elsukov EP. Determination of nanoparticle sizes by X-ray 
diffraction. Colloid Journal. 2012; 74(6):675-685. http://dx.doi.
org/10.1134/S1061933X12060051
22. Stoner EC and Wohlfarth EP. A Mechanism of Magnetic 
Hysteresis in Heterogeneous Alloys. Philosophical Transactions 
of the Royal Society A. 1948; 240(826):599-642. http://dx.doi.
org/10.1109/TMAG.1991.1183750
23. Coey J. Noncollinear spin arrangement in ultrafine 
ferromagnetic crystallites. Physical Review Letters. 1971; 
27:1140-3. http://dx.doi.org/10.1103/PhysRevLett.27.1140
24. Varanda LC, Jafelicci P Jr, O’Grady K, González-Carreño 
T, Morales MP, Muñoz T et al. Structural and magnetic 
transformation of monodispersed iron oxide particles in a 
reducing atmosphere. Journal of Applied Physics. 2002; 
92(4):2079. http://dx.doi.org/10.1063/1.1496124
25. Sato T, Iijima T, Sekin M, Inagaki N. Magneticproperties of 
ultrafine ferrite particles. Journal of Magnetism and Magnetic 
Materials 1987; 65:252. http://dx.doi.org/10.1016/0304-
8853(87)90044-8
26. Unsoy G, Yalcin S, Khodadust R, Gunduz G, Gunduz U. 
Synthesis optimization and characterization of chitosan-coated 
iron oxide nanoparticles produced for biomedical applications. 
Journal of Nanoparticle Research. 2012; 14: 964. http://dx.doi.
org/10.1007/s11051-012-0964-8
27. Gomez-Lopera SA, Plaza RC, Delgado AV. Synthesis and 
characterization of spherical magnetite/biodegradable polymer 
composite particles. Journal of Colloid and Interface Science. 
2001; 240(1):40-7. http://dx.doi.org/10.1006/jcis.2001.7579
28. Voit W, Kim DK, Zapka W, Muhammed M, Rao KV. Magnetic 
behavior of coated superparamagnetic iron oxide nanoparticles 
in ferrofluids. Materials Research Society. 2001; 676:Y7.8 .1-6. 
http://dx.doi.org/10.1557/PROC-676-Y7.8
29. Bradbury A, Menear S, O’Grady K, Chantrell RW. Magnetic 
size determination for interacting fine particle systems. IEEE 
Transactions on Magnetics. 1984; 20(5):1846-8. http://dx.doi.
org/10.1109/TMAG.1984.1063338
30. Taylor AP, Barry JC, Webb RI. Structural and morphological 
anomalies in magnetosomes: possible biogenicorigin 
for magnetite in ALH84001. Journal of Microscopy. 
2001; 201(1):84. http://dx.doi.org/10.1046/j.1365-
2818.2001.00760.x
31. Zhou WL, Wang K-Y, O’Connor CJ, Tang J. Granular growth 
of Fe3O4 thin films and its antiphase boundaries prepared by 
pulsed laser deposition. Journal of Applied Physics. 2001; 
89(11): 7398-400. http://dx.doi.org/10.1063/1.1358831
32. Kim DK, Zhang Y, Voit W, Rao KV, Kehr J, Bjelke B, 
Muhammed M. Superparamagnetic iron oxide nanoparticles for 
bio-medical applications. Scripta Materialia 2001; 44:1713-7. 
http://dx.doi.org/10.1016/S1359-6462(01)00870-3
33. Sharma VK and Waldner F. Superparamagnetic and 
ferrimagnetic resonance of ultrafine Fe3O4 particles in 
ferrofluids. Journal of Applied Physics. 1977; 48(10):4298-
4302. http://dx.doi.org/10.1063/1.323418
34. Raikher YL and Stepanov VI. Ferromagnetic resonance in 
a suspension of single-domain particles. Physical Review 
B. 1994; 50(9):6250-6259. http://dx.doi.org/10.1103/
PhysRevB.50.6250
35. Morais PC, Lara MCF and Skeff Neto K. Electron spin 
resonance in superparamagnetic particles dispersed in a 
non-magnetic matrix. Philosophical Magazine Letters. 1987; 
55(4):181-183. http://dx.doi.org/10.1080/09500838708207553
36. Nagata K and Ishihara A. ESR of ultrafine magnetic particles. 
Journal of Magnetism and Magnetic Materials. 1992; 
104-107(3):1571-1573. http://dx.doi.org/10.1016/0304-
8853(92)91459-7
37. Sastry MD, Babu Y, Goyal PS, Mehta RV, Upadhyay RV 
and Srinivas D. Electron magnetic resonance of ferrofluids: 
Evidence for anisotropic resonance at 77 K in samples 
cooled in a magnetic field. Journal of Magnetism and 
Magnetic Materials. 1995; 149(1-2):64-66. http://dx.doi.
org/10.1016/0304-8853(95)00339-8
38. Berger R, Bissey JC, Kliava J, Daubric H and Estournes C. 
Temperature dependence of superparamagnetic resonance of 
iron oxide nanoparticles. Journal of Magnetism and Magnetic 
Materials. 2001; 234(3):535-544. http://dx.doi.org/10.1016/
S0304-8853(01)00347-X
39. Hseih CT, Huang WL and Lue JT. The change from 
paramagnetic resonance to ferromagnetic resonance for iron 
nanoparticles made by the sol-gel method. Journal of Physics 
and Chemistry of Solids. 2002; 63(5):733-741. http://dx.doi.
org/10.1016/S0022-3697(01)00222-0
40. Gamarra LF, Pontuschka WM, Mamani JB, Cornejo DR, 
Oliveira TR, Vieira, ED et al. Magnetic characterization by 
SQUID and FMR of a biocompatible ferrofluid based on Fe3O4. 
Journal of Physics: Condensed Matter. 2009; 21:115104. http://
dx.doi.org/10.1088/0953-8984/21/11/11510
41. Gamarra LF, Mamani JB, Carneiro SM, Fabris JD, Ferreira RV, 
Domingues RZ et al. Characterization of Superparamagnetic 
Iron Oxide Coated with Silicone Used as Contrast Agent for 
Magnetic Resonance Image for the Gastrointestinal Tract. 
Journal of Nanoscience and Nanotechnology. 2010; 10:1153-
1158. http://dx.doi.org/10.1166/jnn.2010.1843
42. Kinnari P, Upadhyay RV and Mehta RV. Magnetic properties 
of Fe-Zn ferrite substituted ferrofluids. Journal of Magnetism 
and Magnetic Materials. 2002; 252:35-38. http://dx.doi.
org/10.1016/S0304-8853(02)00652-2
43. Chen X, Lv H, Ye M, Wang S, Ni E, Zeng F et al. Novel 
superparamagnetic iron oxide nanoparticles for tumor 
embolization application: preparation, characterization and 




Synthesis and Characterization of Fe3O4 Nanoparticles with Perspectives in Biomedical Applications
44. Mamani JB, Malheiros JM, Cardoso EF, Tannús A, Silveira PH 
and Gamarra LF. In vivo magnetic resonance imaging tracking 
of C6 glioma cells labeled with superparamagnetic iron oxide 
nanoparticles. Einstein (Sao Paulo). 2012; 10(2):164-70. http://
dx.doi.org/10.1590/S1679-45082012000200009
45. Mamani JB, Pavon LF, Miyaki LA, Sibov TT, Rossan F, 
Silveira PH et al. Intracellular labeling and quantification 
process by magnetic resonance imaging using iron oxide 
magnetic nanoparticles in rat C6 glioma cell line. Einstein 
(Sao Paulo). 2012; 10(2):216-221. http://dx.doi.org/10.1590/
S1679-45082012000200016
46. Smith CA, de la Fuente J, Pelaz B, Furlani EP, Mullin M 
and Berry CC. The effect of static magnetic fields and 
tat peptides on cellular and nuclear uptake of magnetic 
nanoparticles. Biomaterials. 2010; 31(15):4392-400. http://
dx.doi.org/10.1016/j.biomaterials.2010.01.096
47. Landázuri N, Tong S, Suo J, Joseph G, Weiss D, Sutcliffe 
DJ et al. Magnetic Targeting of Human Mesenchymal Stem 
Cells with Internalized Superparamagnetic Iron Oxide 
Nanoparticles. Small. 2013. http://dx.doi.org/10.1002/
smll.201300570
48. Chertok B, David AE, Huang Y and Yang VC. Glioma 
selectivity of magnetically targeted nanoparticles: a role 
of abnormal tumor hydrodynamics. Journal of Controlled 
Release. 2007; 122(3):315-23. http://dx.doi.org/10.1016/j.
jconrel.2007.05.030
49. Jordan A, Scholz R, Maier-Hauff K, van Landeghem 
FK, Waldoefner N, Teichgraeber U et al. The effect of 
thermotherapy using magnetic nanoparticles on rat malignant 
glioma. Journal of Neuro-Oncology. 2006; 78(1):7-14. http://
dx.doi.org/10.1007/s11060-005-9059-z
50. Silva AC, Oliveira TR, Mamani JB, Malheiros SM, Malavolta 
L, Pavon LF et al. Application of hyperthermia induced 
by superparamagnetic iron oxide nanoparticles in glioma 
treatment. International Journal of Nanomedicine. 2011; 
6:591-603. http://dx.doi.org/10.2147/IJN.S14737
51. Chertok B, David AE and Yang VC. Brain tumor targeting of 
magnetic nanoparticles for potential drug delivery: Effect of 
administration route and mangetic field topography. Journal 
of Controlled Release. 2011; 155(3):393-399. http://dx.doi.
org/10.1016/j.jconrel.2011.06.033
2014; 17(3) 549
